Akari Therapeutics PLC Share Price Today: Live Updates & Key Insights
Akari Therapeutics PLC share price today is $8.53, up -6.45%. The stock opened at $9.13 against the previous close of $9.3, with an intraday high of $9.13 and low of $8.55.
Akari Therapeutics PLC Share Price Chart
Akari Therapeutics PLC
Akari Therapeutics PLC Share Price Performance
Akari Therapeutics PLC Institutional Holdings
Akari Therapeutics PLC Market Status
Akari Therapeutics PLC Fundamentals
Market Cap 16.28 M
PB Ratio 1.1941
PE Ratio 0.0
Enterprise Value 14.24 M
Total Assets 47.89 M
Volume 28115
Akari Therapeutics PLC Company Financials
About Akari Therapeutics PLC & investment objective
Company Information Akari Therapeutics, Plc, an oncology company, develops antibody-drug conjugates (ADC) for cancer-killing toxins. Its lead payload is PH1 to disrupt the function of spliceosomes and to trigger an immune response that leads to additional cancer cell killing. The company's lead product candidate is AKTX-101, a preclinical stage trop2-targeting ADC that combines PH1 with the trop2 antibody to treat solid tumor cancer types, including lung, breast, bladder, head and neck, gastric, pancreatic, colon, prostate, and others. Its payloads include PH1 is a novel payload that is a spliceosome modulator designed to disrupt RNA splicing within cancer cells. The company also develops AKTX-102, a novel bispecific ADC that utilizes PH1 as its payload to treat various solid tumor cancers. Akari Therapeutics, Plc is headquartered in Tampa, Florida.
Organisation Biotechnology
Employees 5
Industry Biotechnology
CEO Mr. Abizer Gaslightwala
Trading and brokerage services provided by
Technology Services provided by Motilal Oswal Financial Services:
Disclaimer: These services are not for exchange traded products. The securities quoted are exemplary and not recommendatory. Please be informed that US Stocks are not exchange traded funds in India and Motilal Oswal Financial Services acts in the capacity of facilitator of this product. All disputes with respect to the transaction facilitation services, would not have access to Indian Exchange investor redressal forum or Arbitration mechanism in India. T&C apply*
Take your next step
Akari Therapeutics PLC FAQs
What is the share price of Akari Therapeutics PLC today?
The current share price of Akari Therapeutics PLC is $8.53.
Can I buy Akari Therapeutics PLC shares in India?
Yes, Indian investors can buy Akari Therapeutics PLC shares by opening an international trading and demat account with Motilal Oswal.
How to buy Akari Therapeutics PLC shares in India?
You can easily invest in Akari Therapeutics PLC shares from India by:
- Direct Investment:
Opening an international trading account with Motilal Oswal which includes KYC verification in the US. Your account gets activated in a few minutes to a few hours, after which you can start adding funds in USD balance to buy Akari Therapeutics PLC shares. - Indirect Investment:
Under this form of investment, you can choose either a Mutual Fund (MF) or an Exchange-Traded Fund (ETF) that invests in global shares and start investing in shares of Akari Therapeutics PLC.
Can I buy fractional shares of Akari Therapeutics PLC?
Yes, many platforms allow you to buy fractional shares starting from as low as $1.
What is the market capitalization value of Akari Therapeutics PLC?
Akari Therapeutics PLC has a market cap of $16.28 M.
In which sector does Akari Therapeutics PLC belong?
Akari Therapeutics PLC operates in the Biotechnology sector.
What documents are required to invest in Akari Therapeutics PLC stocks?
To invest, you typically need:
What is the PE and PB ratio of Akari Therapeutics PLC?
The PE ratio of Akari Therapeutics PLC is N/A and the PB ratio is 1.19.